Cargando…
Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
BACKGROUND: Immune checkpoint blocker (ICB) has shown significant clinical activity in melanoma. However, there are no clinically approved biomarkers to aid patient selection. We aimed to identify patients with advanced or metastatic melanoma who are likely to benefit from ICB monotherapy using easi...
Autores principales: | Byun, Hwa Kyung, Chang, Jee Suk, Jung, Minkyu, Koom, Woong Sub, Chung, Kee Yang, Oh, Byung Ho, Roh, Mi Ryung, Kim, Kyung Hwan, Lee, Choong-Kun, Shin, Sang Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190329/ https://www.ncbi.nlm.nih.gov/pubmed/34123816 http://dx.doi.org/10.3389/fonc.2021.659754 |
Ejemplares similares
-
Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy
por: Lee, Jeongshim, et al.
Publicado: (2020) -
Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients
por: Kim, Hyun Ju, et al.
Publicado: (2019) -
A practical review of watch-and-wait approach in rectal cancer
por: Byun, Hwa Kyung, et al.
Publicado: (2023) -
Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer
por: Lee, Joongyo, et al.
Publicado: (2021) -
Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer
por: Yang, Gowoon, et al.
Publicado: (2022)